| Model for growth hormone receptor activation based on subunit rotation within a receptor dimer RJ Brown, JJ Adams, RA Pelekanos, Y Wan, WJ McKinstry, K Palethorpe, ... Nature structural & molecular biology 12 (9), 814-821, 2005 | 457 | 2005 |
| Bioluminescence resonance energy transfer (BRET) for the real-time detection of protein-protein interactions KDG Pfleger, RM Seeber, KA Eidne Nature protocols 1 (1), 337-345, 2006 | 264 | 2006 |
| Constitutive and agonist-dependent homo-oligomerization of the thyrotropin-releasing hormone receptor: detection in living cells using bioluminescence resonance energy transfer KM Kroeger, AC Hanyaloglu, RM Seeber, LEC Miles, KA Eidne Journal of Biological Chemistry 276 (16), 12736-12743, 2001 | 252 | 2001 |
| αvβ3 Integrin interacts with the transforming growth factor β (TGFβ) type II receptor to potentiate the proliferative effects of TGFβ1 in living human lung fibroblasts AK Scaffidi, N Petrovic, YP Moodley, M Fogel-Petrovic, KM Kroeger, ... Journal of Biological Chemistry 279 (36), 37726-37733, 2004 | 136* | 2004 |
| Demonstration of improvements to the bioluminescence resonance energy transfer (BRET) technology for the monitoring of G protein–coupled receptors in live cells M Kocan, HB See, RM Seeber, KA Eidne, KDG Pfleger SLAS Discovery 13 (9), 888-898, 2008 | 114 | 2008 |
| Plasma leptin-binding activity and hypothalamic leptin receptor expression during pregnancy and lactation in the rat RM Seeber, JT Smith, BJ Waddell Biology of Reproduction 66 (6), 1762-1767, 2002 | 114 | 2002 |
| Homo-and hetero-oligomerization of thyrotropin-releasing hormone (TRH) receptor subtypes: differential regulation of β-arrestins 1 and 2 AC Hanyaloglu, RM Seeber, TA Kohout, RJ Lefkowitz, KA Eidne Journal of Biological Chemistry 277 (52), 50422-50430, 2002 | 106 | 2002 |
| The duffy antigen/receptor for chemokines exists in an oligomeric form in living cells and functionally antagonizes CCR5 signaling through hetero-oligomerization A Chakera, RM Seeber, AE John, KA Eidne, DR Greaves Molecular pharmacology 73 (5), 1362-1370, 2008 | 105 | 2008 |
| Identification and profiling of CXCR3–CXCR4 chemokine receptor heteromer complexes AO Watts, MMH Van Lipzig, WC Jaeger, RM Seeber, M Van Zwam, ... British journal of pharmacology 168 (7), 1662-1674, 2013 | 79 | 2013 |
| Heteromerization of angiotensin receptors changes trafficking and arrestin recruitment profiles ER Porrello, KDG Pfleger, RM Seeber, H Qian, C Oro, F Abogadie, ... Cellular signalling 23 (11), 1767-1776, 2011 | 77 | 2011 |
| Transactivation of RAGE mediates angiotensin-induced inflammation and atherogenesis RJ Pickering, C Tikellis, CJ Rosado, D Tsorotes, A Dimitropoulos, M Smith, ... The Journal of clinical investigation 129 (1), 406-421, 2019 | 76 | 2019 |
| Identification and profiling of novel α1A-adrenoceptor-CXC chemokine receptor 2 heteromer S Mustafa, HB See, RM Seeber, SP Armstrong, CW White, S Ventura, ... Journal of Biological Chemistry 287 (16), 12952-12965, 2012 | 69 | 2012 |
| Cytoplasmic terminus of vacuolar type proton pump accessory subunit Ac45 is required for proper interaction with V0 domain subunits and efficient osteoclastic bone resorption H Feng, T Cheng, NJ Pavlos, KHM Yip, A Carrello, R Seeber, K Eidne, ... Journal of biological chemistry 283 (19), 13194-13204, 2008 | 55 | 2008 |
| Application of G Protein-Coupled Receptor-Heteromer Identification Technology to Monitor β-Arrestin Recruitment to G Protein-Coupled Receptor Heteromers HB See, RM Seeber, M Kocan, KA Eidne, KDG Pfleger Assay and drug development technologies 9 (1), 21-30, 2011 | 54 | 2011 |
| Mutations of vasopressin receptor 2 including novel L312S have differential effects on trafficking A Tiulpakov, CW White, RS Abhayawardana, HB See, AS Chan, ... Molecular endocrinology 30 (8), 889-904, 2016 | 48 | 2016 |
| Biocompatibility of semiconducting AlGaN/GaN material with living cells A Podolska, S Tham, RD Hart, RM Seeber, M Kocan, M Kocan, UK Mishra, ... Sensors and Actuators B: Chemical 169, 401-406, 2012 | 41 | 2012 |
| Enhanced BRET technology for the monitoring of agonist-induced and agonist-independent interactions between GPCRs and β-arrestins M Kocan, MB Dalrymple, RM Seeber, BJ Feldman, KDG Pfleger Frontiers in Endocrinology 1, 12, 2011 | 41 | 2011 |
| Characterization of three vasopressin receptor 2 variants: an apparent polymorphism (V266A) and two loss-of-function mutations (R181C and M311V) SP Armstrong, RM Seeber, MA Ayoub, BJ Feldman, KDG Pfleger PloS one 8 (6), e65885, 2013 | 30 | 2013 |
| Molecular determinants of orexin receptor‐arrestin‐ubiquitin complex formation WC Jaeger, RM Seeber, KA Eidne, KDG Pfleger British Journal of Pharmacology 171 (2), 364-374, 2014 | 20 | 2014 |
| Profiling epidermal growth factor receptor and heregulin receptor 3 heteromerization using receptor tyrosine kinase heteromer investigation technology MA Ayoub, HB See, RM Seeber, SP Armstrong, KDG Pfleger PloS one 8 (5), e64672, 2013 | 17 | 2013 |
Professor Kevin PflegerThe University of Western Australia and Harry Perkins Institute of Medical ResearchVerified email at uwa.edu.au
